Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trial-Reference-Cited by-同舟云学术

Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trial

Published:2011-08 Issue:35 Volume:29 Page:6059-6067
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Aide Pedro,Dobaño Carlota,Sacarlal Jahit,Aponte John J.,Mandomando Inácio,Guinovart Caterina,Bassat Quique,Renom Montse,Puyol Laura,Macete Eusebio,Herreros Esperanza,Leach Amanda,Dubois Marie-Claude,Demoitie Marie-Ange,Lievens Marc,Vekemans Johan,Loucq Christian,Ballou W. Ripley,Cohen Joe,Alonso Pedro L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference27 articles.

1. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine;Gordon;J Infect Dis,1995

2. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group;Stoute;N Engl J Med,1997

3. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial;Bojang;Lancet,2001

4. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial;Alonso;Lancet,2005

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macromolecular Cargo Encapsulation via In Vitro Assembly of Two‐Component Protein Nanoparticles;Advanced Healthcare Materials;2024-02-11

2. RTS,S/AS02A Malaria Vaccine-Induced IgG Responses Equally Recognize Native-Like Fucosylated and Nonfucosylated Plasmodium falciparum Circumsporozoite Proteins;The Journal of Infectious Diseases;2023-10-27

3. Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults;Clinical Pharmacology: Advances and Applications;2023-03

4. RTS,S/AS02A malaria vaccine-induced IgG responses equally recognize native-like fucosylated and non-fucosylated Plasmodium falciparum circumsporozoite proteins;2023-01-10

5. Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens;Cell Reports Medicine;2022-10